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Summary
The assembly of the Escherichia coli outer membrane
(OM) is poorly understood. Although insight into fun-
damental cellular processes is often obtained from
studying mutants, OM-defective mutants have not
been very informative because they generally have
nonspecific permeability defects. Here we show that
toxic small molecules can be used in selections em-
ploying strains with permeability defects to create
particular chemical conditions that demand specific
suppressor mutations. Suppressor phenotypes are
correlated with the physical properties of the small
molecules, but the mutations are not in their target
genes. Instead, mutations allow survival by partially
restoring membrane impermeability. Using “chemical
conditionality,” we identified mutations in yfgL, and,
here and in the accompanying paper by Wu et al. pub-
lished in this issue of Cell (Wu et al., 2005), we show
that YfgL is part of a multiprotein complex involved
in the assembly of OM  barrel proteins. We posit that
panels of toxic small molecules will be useful for gen-
erating chemical conditionalities that enable identifi-
cation of genes required for organelle assembly in
other organisms.
Introduction
The outer membrane (OM) of Escherichia coli is an
asymmetric bilayer in which the outer leaflet is com-
prised largely of lipopolysaccharides (LPS) and the in-
ner leaflet is comprised of phospholipids (Figure 1; Smit
et al., 1975; Kamio and Nikaido, 1976). β barrel proteins
span the bilayer, and lipoproteins are attached to the
inner surface by lipid anchors (for recent review, see
Nikaido [2003]). This organelle serves as a protective
barrier preventing entry of toxic substances, such as
detergents and antibiotics, into the cell (Figure 1).
The biogenesis of the OM is not well understood, in
part because methods to probe the assembly process
have not been developed. Mutations in a large number
of genes cause a general “leakiness” that is manifested*Correspondence: tsilhavy@molbio.princeton.eduas sensitivity to bile salts, for example, but because this
mutant phenotype is not distinct, it is difficult to assess
whether or not these gene products function directly in
the OM assembly process. Here we show that certain
types of small molecules can be used to create condi-
tions that enable highly specific phenotypes to emerge
in selections for suppressors of mutations that confer
“leaky” phenotypes. These highly specific phenotypes,
which are defined by the type of toxic small molecules
that can or cannot enter and prevent growth of the mu-
tant cell, are conferred by suppressor mutations in par-
ticular genes. We have exploited this chemical condi-
tionality to identify genes involved in OM biogenesis,
and this, in turn, provides a starting point for dissecting
the machinery involved in membrane assembly. We be-
lieve that this is a general strategy that can be used for
probing the assembly of many biological membranes
and organelles.
The work described here was initiated to investigate
the mechanism of action of chlorobiphenyl vancomycin
(CBPV) and moenomycin (compounds 2 and 4, respec-
tively, Figure 2A), two antibiotics that inhibit bacterial
cell wall (peptidoglycan) synthesis. We performed ge-
netic selections to identify the target(s) of these antibi-
otics by searching for mutations that confer resistance.
Because in E. coli the OM surrounds the peptidoglycan
layer and this membrane is naturally impermeable to
these compounds, we used an E. coli strain with an OM
defect that allows the entry of these antibiotics (Eggert
et al., 2001). The increased permeability of the OM of
this mutant strain is caused by the imp4213 allele, an
in-frame deletion allele in the imp (increased membrane
permeability) gene, which encodes a protein essential
for OM assembly in E. coli (Braun and Silhavy, 2002).
Cells carrying this allele are sensitive to antibiotics and
detergents (Figure 1; Sampson et al., 1989) and are fre-
quently used to study mechanisms of action of com-
pounds that cannot penetrate the OM of wild-type
E. coli (for example, see Singh et al. [2003]).
Here we show that the only mutations that answer
selections for resistance to either CBPV or moeno-
mycin but not vancomycin or erythromycin (Figure 2A)
are loss-of-function mutations in yfgL. However, we
demonstrate that the loss of YfgL suppresses sensitiv-
ity to these antibiotics not by altering the drug target
but rather by altering the permeability of the OM of
imp4213 cells (Figure 1), since we have found that yfgL
mutations also suppress sensitivity of imp4213 cells to
bile salts, a detergent that disrupts membrane integrity
(compound 9, Figure 2A). Although Imp function is
essential in E. coli and has been implicated in mem-
brane biogenesis (Braun and Silhavy, 2002), YfgL is not
an essential protein in wild-type cells, and nothing was
known of its function prior to the work reported here
and in the accompanying paper published in this issue
of Cell (Wu et al., 2005). The genetic interactions be-
tween imp and yfgL that we have uncovered using
chemical probes indicate a role for YfgL (a putative OM
lipoprotein) in OM biogenesis as well.
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308Figure 1. Chemical Conditionality
The E. coli cell (bottom of figure) is composed of four compartments: cytoplasm, inner membrane, periplasm, and outer membrane. The inner
membrane, periplasm, and outer membrane are collectively called the cell envelope. While the inner membrane (IM, top left panel) is a
phospholipid (PL) bilayer, the inner leaflet of the outer membrane (OM) is composed of PL, but its outer leaflet is composed of lipopolysaccha-
rides (LPS). No membrane proteins are shown for simplicity. The peptidoglycan (PG) layer resides in the periplasm and is a structure essential
for viability. The three panels at the top of the figure show the permeability status of the outer membrane in three strains: wild-type (left
panel), imp4213 (center panel), and imp4213 yfgL− (right panel). The outer membrane (OM) of a wild-type strain (left panel) acts as a barrier
that prevents the entry of some antibiotics (represented as diamonds and circles) that inhibit enzymes (PG enzyme) involved in peptidoglycan
(PG) biosynthesis. Because neither antibiotic can penetrate the wild-type OM, they cannot reach their target in the periplasm, and therefore
the cell survives in their presence. In an imp4213 strain (center panel), the defective OM (represented by a change in color to light gray,
compare to left panel) is not impermeable to either antibiotic. Both antibiotics can pass through the OM into the periplasm where they bind
to their target. Since binding of either antibiotic to the PG enzyme inhibits peptidoglycan biosynthesis, the cell dies in the presence of either
compound. Assuming that the “circle” antibiotic represents either CBPV or moenomycin, we selected for mutations that confer resistance to
either compound in imp4213 cells. The only mutation that specifically confers resistance to CBPV or moenomycin (circles) but not other
antibiotics (diamonds) is a loss-of-function mutation in yfgL. In imp4213 yfgL− (right panel), the loss of YfgL causes a decrease in the
permeability of the OM (represented by a change in color to dark gray, compare to center panel). Since the barrier function of the OM in
imp4213 yfgL− has been partially restored, neither CBPV nor moenomycin (circles) can pass through the OM, but the antibiotic represented
by a diamond still can. Therefore, imp4213 yfgL− cells survive in the presence of either CBPV or moenomycin but die in the presence of
other antibiotics.Our work demonstrates that toxic small molecules R
can be exploited not only to probe their targets but also
to identify factors involved in the biogenesis of mem- T
abranes that surround the compartment where the target
for such toxic compounds resides. Our results also in- I
sdicate that the defects in outer membrane permeability
caused by imp4213 can be corrected to varying de- m
(grees. Small chemical probes can be classified in a
continuum that is based on the quantity and quality of i
dsuppressor that each can elicit when used in selections
for resistance. We discuss the chemical basis for this n
mcontinuum and propose an expanded role for small
molecules in non-target-directed chemical genetic an- t
palysis of membranes and organelle biogenesis.esults
he Remarkable Specificity of CBPV
nd Moenomycin in imp4213 Strains
n our preliminary investigation we had selected for
pontaneous mutants resistant to CBPV and moeno-
ycin in the imp4213 background and discovered yfgL
Eggert et al., 2001). In order to find additional factors
nvolved in the same pathway as YfgL, and perhaps the
irect targets of these inhibitors, we repeated our origi-
al selections for spontaneous CBPV- and moeno-
ycin-resistant mutants on a larger scale. Strikingly,
he only mutations that we obtained were 34 more inde-
endent IS1E element insertions in the yfgML locus ori-
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309Figure 2. Small Molecules and the Suppressors of imp4213 that They Elicit
(A) Chemical structure and mechanism of action of the toxic small molecules used in this study. Numbers in parenthesis are used in text to
refer to each compound.
(B) Toxic small molecules can be arranged in a continuum in which there is a correlation between the quantity and quality of suppressors
that they elicit in imp4213 cells. See Results and Discussion sections for a detailed explanation of this continuum.
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310ented in the opposite direction from the transcription of a
cthe yfgML operon, similar to those isolated previously
(Eggert et al., 2001). Because this locus seemed to be i
ca hotspot for IS1E insertions, we subjected E. coli
imp4213 to chemical mutagenesis with N-methyl-N- t
rnitrosoguanidine (NTG) and then selected for mutants
resistant to moenomycin. All of the base substitution w
smutations obtained were recessive null alleles of yfgL
or missense alterations of imp4213 itself. All of the yfgL t
fmutants were found to be crossresistant to CBPV but
not to vancomycin or to other antibiotics. In contrast, o
ethe intragenic suppressors in imp4213 increased resis-
tance not only to moenomycin and CBPV but to other t
iantibiotics as well (Table 1 and see below). We con-
clude that the only mutations that answer the selection t
Cspecifically for resistance to CBPV and moenomycin in
the imp4213 background are those that abolish or t
tgreatly reduce production of functional YfgL. It is sur-
prising that the lack of a putative outer membrane lipo-
tprotein (YfgL) selectively confers resistance to a subset
of compositionally dissimilar antibiotics while exclud- c
bing molecules that are structurally similar.
t
dThe yfgL Mutations Alter OM Permeability
Cells carrying the imp4213 allele are sensitive not only l
fto antibiotics but also to detergents such as bile salts.
Therefore, since MacConkey agar contains bile salts, a
strains carrying imp4213 cannot grow on this medium
(Sampson et al., 1989). However, we discovered that m
timp4213 yfgL::IS1E double mutants do grow on Mac-
Conkey agar. Thus, imp4213 yfgL::IS1E double mutants r
tare resistant to bile salts, CBPV, and moenomycin while
remaining sensitive to other antibiotics, such as vanco- N
amycin (Table 1).
As indicated above, selections for resistance to w
aCBPV or moenomycin in the imp4213 background
specifically yield yfgL mutants. We next tested whether a
lselection for bile salt resistance was also specific for
yfgL mutants. By selecting for growth on lactose Mac- m
eConkey agar, we obtained spontaneous mutants resis-
tant to bile salts at a frequency of ca. 4 × 10−7. After o
evarious independent selections, we determined that
30%–60% of the bile salt-resistant mutants were also s
CBPV resistant. Mutations that conferred resistance toTable 1. Phenotypes of imp and yfgL Mutants
Phenotypesa Inhibition Zone (mm)b
Relevant genotypes Mac CBPV Van Bac Nov Rif Em
imp4213 S S S 18 16 23 17
imp61 R R R 10 ND 17 13.5
imp4213 yfgL8 R R S 17 14 26 20
imp4213 yfgL::IS1E R R S
imp+ R R R ND ND 7.5 ND
imp+ yfgL::kan 8 10 17 10
imp+ yfgL::IS1E 12 9 19 10
a Sensitivity to bile salts (Mac), CBPV, and vancomycin (Van) was determined by assessing growth on plates containing these compounds as
described in Experimental Procedures. Strains that grow in the presence of the compound were categorized as resistant (R), while those that
did not grow were categorized as sensitive (S).
b Overnight cultures of the indicated strains were plated on LB agar using a soft agar overlay. Disks containing antibiotics were placed onto
the solidified agar surface. The diameter of the zone of inhibition of growth observed after overnight incubation is shown in mm. The disks
used were 6 mm in diameter. Bac refers to bacitracin, Nov to novobiocin, Rif to rifampin, and Em to erythromycin; ND indicates no detectable
zone of inhibition.bile salts only were not linked to either yfgL or imp4213nd will not be discussed any further. Mutations that
onferred resistance to both bile salts and CBPV were
n either the yfgML locus or in imp, and the latter also
onferred resistance to vancomycin (see below). All of
he mutations that mapped to the yfgML locus were
ecessive loss-of-function alleles, since expression of
ild-type yfgL in trans restored sensitivity to both bile
alts and CBPV (data not shown). Thus, like the selec-
ions for resistance to CBPV or moenomycin, selections
or bile salt resistance yielded intragenic suppressors
f imp4213 and loss-of-function alleles of yfgL. How-
ver, unlike the former, selections for bile salt resis-
ance also yielded mutations other than those in
mp4213 or yfgL. Regardless of the selection employed,
he only mutations that specifically give resistance to
BPV and moenomycin in the imp4213 background are
hose that abolish or greatly reduce production of func-
ional YfgL.
Although selections for CBPV or moenomycin resis-
ance only yielded one type of mutation in the yfgL lo-
us (IS1E element insertions, see above), selections for
ile salt resistance yielded multiple types of yfgL muta-
ions. For example, yfgL8 is an in-frame 12 base pair
eletion (codons 252–255). This allele is a recessive,
oss-of-function mutation (data not shown), and it con-
ers the same resistance phenotypes as the yfgL::IS1E
llele (Table 1).
Unlike the yfgL mutations, the intragenic suppressor
utation imp61 increases resistance to all the other an-
ibiotics tested (Table 1). Phenotypically, this mutation
esembles the intragenic suppressors of imp4213 ob-
ained upon selection for CBPV resistance following
TG mutagenesis (see above). Indeed, DNA sequence
nalysis revealed that the imp61 mutation (codon 274
as changed from AAC to AUC; N274I at the amino
cid level) was identical to one of the imp suppressor
lleles obtained by NTG mutagenesis.The other imp al-
eles obtained by NTG mutagenesis contain multiple
utations reflecting the heavy level of mutagenesis
mployed. In any event, unlike the yfgL suppressors, all
f the intragenic suppressors in imp4213 that we have
xamined suppress or partially suppress all of the imp
ensitivity phenotypes.
Thus, there is a continuum of suppressor quantityand quality (Figure 2B). Bile salts are at one end of the
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311continuum (left in Figure 2B). There are multiple sup-
pressors of bile salt sensitivity, and these suppressors
may or may not suppress sensitivity of compounds to
the right. At the other end of the continuum is vancomy-
cin or erythromycin. Only intragenic imp mutations sup-
press sensitivity to these compounds, and these sup-
pressors always suppress sensitivity to compounds to
the left. The yfgL suppressors of CBPV and moeno-
mycin sensitivity lie in the middle of this continuum.
They suppress sensitivity to bile salts but not sensitivity
to vancomycin or erythromycin.
Because yfgL mutations in the imp4213 background
confer resistance to bile salts, CBPV, and moenomycin,
it is likely that the lack of YfgL alters some aspect of
the OM permeability defect caused by imp4213. Resis-
tance to CBPV and moenomycin requires this particular
alteration absolutely. Since this change in permeability
does not affect sensitivity of the imp4213 strain to the
closely related molecule vancomycin, we infer that the
striking specificity of CBPV relates to some physical
property of this molecule, perhaps its increased hydro-
phobicity. In any event, this change in permeability sug-
gests a functional relationship between Imp and YfgL,
and this in turn suggests a role for YfgL in OM bio-
genesis.
The Levels of Imp and YfgL in Various
Mutant Backgrounds
Since low levels of wild-type Imp have been reported
to lead to OM permeability defects (Abe et al., 2003),
we determined by Western blot analysis whether any
of the suppressors affected Imp levels. The imp4213
mutation is a 23 codon deletion (Braun and Silhavy,
2002), and, therefore, the mutant Imp4213 protein mi-
grated faster than wild-type Imp on an SDS polyacryl-
amide gel, reflecting this loss of mass (Figure 3A). We
found that the levels of the mutant Imp4213 protein
were lower than wild-type Imp, and this difference was
especially apparent in overnight cultures (Figure 3A). By
monitoring Imp4213 levels during cell growth, we see
that levels of Imp4213 decrease early in stationary
phase (data not shown). We believe that the lower
levels of Imp4213 are not due to decreased synthesis,
since the levels of SurA, which is cotranscribed with
imp (Braun and Silhavy, 2002), remain unchanged in
imp4213 cells (data not shown). Instead, the lower
levels of Imp4213 are likely the result of a defect in
Imp4213 biogenesis.
Western blot analysis showed that the Imp levels ex-
pressed from the imp61 allele were not significantly dif-
ferent from those expressed from imp4213 during loga-
rithmic phase (data not shown). However, Imp levels
were higher in the imp61 mutant than in imp4213 in late
stationary cultures but still much lower than wild-type
(Figure 3B).
Since the yfgL8 allele is an in-frame deletion, the
YfgL8 mutant protein migrates slightly faster than wild-
type on SDS gels (Figure 3B). Although this mutation
destroys YfgL function, it does not destabilize the pro-
tein, since the levels of the mutant YfgL were the same
as wild-type. In addition, during logarithmic growth,
Imp4213 levels were not affected by the presence of
the yfgL8 allele (data not shown). However, samples
from overnight cultures of the imp4213 yfgL8 doubleFigure 3. Levels of Outer Membrane Proteins in imp4213 and Sup-
pressor Strains
(A) Western blot analysis of Imp levels in whole cells that have been
grown logarithmically (LOG) or overnight (O/N) in LB. The 23 codon
internal deletion in imp4213 results in decreased levels of the mu-
tant Imp when compared to wild-type (wt).
(B) Western blot analysis of Imp, LamB, YfgL, and OmpA was con-
ducted on overnight cultures. When compared to wild-type (wt),
the imp4213 mutant has reduced levels of Imp but comparable
levels of LamB, YfgL, and OmpA, and the intragenic suppressor
imp61 does not change them. The yfgL8 allele carries a 4 codon
internal deletion that does not affect YfgL stability. However, this
strain contains reduced levels of LamB and OmpA. This mutation
also slightly increases the levels of Imp.mutant contained increased levels of Imp4213 when
compared to the imp4213 single mutant, although they
were still clearly lower than those in the wild-type (Fig-
ure 3B).
Recall that imp61 confers resistance to a broader
spectrum of antibiotics than does yfgL8 (Table 1). Yet
yfgL8 is more effective at stabilizing Imp4213 than
imp61. Clearly, antibiotic resistance does not correlate
with Imp4213 levels, and it is likely that none of the
mutations confer resistance by stabilizing this mutant
protein. It is also clear that none of the imp mutations
have any effect on the levels of YfgL (Figure 3B).
The yfgL Null Mutations Affect Growth Rate
Differently but All Confer Similar
Permeability Phenotypes
We observed that, while imp4213 yfgL::IS1E strains
grow at roughly 25% the rate of their imp4213 parent,
imp4213 yfgL8 strains grow at roughly 75% the rate of
Cell
312the imp4213 single mutant. We confirmed that polarity I
t(i.e., decreased expression of downstream genes)
caused by the IS1E insertion is responsible for the pro- s
tnounced difference in their growth rates. As Figure 4A
shows, yfgK and yfgJ are located immediately down- s
sstream of yfgL and transcribed in the same direction,
which is opposite to that of the only ORF (insA) in the t
yIS1E element. Since the yfgL8 allele is a 12 base pair
in-frame deletion in yfgL and the mutant protein is t
made at wild-type levels, it is not polar. In contrast, the
yfgL::IS1E allele would be expected to decrease yfgKJ (
btranscription if they are in an operon with yfgML (Figure
4A). Since YfgK (also known as EngA and Der) is an d
tessential GTPase (Hwang and Inouye, 2001), it seemed
likely that a decrease in the expression of yfgK due to t
ipolarity could result in slower growth.
To assess the effects of polarity without complica- v
tions owing to the imp4213 allele, we moved the vari-
ous yfgL mutant alleles into an imp+ background. Al- G
Athough the yfgL8 allele did not affect growth, the
yfgL::IS1E allele caused severe growth defects. This d
islow growth phenotype was rescued by pJT37, a
pUC18-based plasmid encoding YfgK only under the n
ccontrol of the derepressed lac promoter (Tan et al.,
2002), but it was not rescued by the control plasmid O
spUC18 (Figure 4B). This result demonstrates that
yfgMLK are cotranscribed and that the growth defects c
nobserved with the IS insertions are due to polarity. This
agrees with the prediction that hisSyfgMLKJ genes s
aconstitute an operon (Bockhorst et al., 2003).
In addition, we obtained a strain carrying a Tn5KAN- cFigure 4. Polar Effects of yfgL::IS1E on yfgK
Expression
(A) The hisSyfgMLKJ genes are predicted to
consitute an operon (Bockhorst et al., 2003).
All the IS1E insertions in yfgL and yfgM iso-
lated in our selections are oriented in the
same direction, with the insA ORF tran-
scribed in opposite direction from the hisS
operon, causing lower expression of the
downstream genes. The kan cassette in the
yfgL::kan allele is transcribed in the same di-
rection as the hisS operon, and its promoter
drives the expression of downstream genes.
(B) Strains carrying the yfgL::IS1E allele grow
more slowly than wild-type (wt). Introduction
of pJT37, a pUC18-based plasmid express-
ing YfgK under the control of the dere-
pressed lac promoter, rescues the growth
defect. Cells were grown on LB agar con-
taining 50 mg/ml of ampicillin.-SceI insertion in yfgL (yfgL::kan), where the transcrip-
ion of the kanamycin resistance cassette is in the
ame orientation as that of yfgMLKJ (Figure 4A), from
he E. coli Genome Project at the University of Wiscon-
in-Madison (insertion is located at position 653). This
train grew at the same rate as wild-type. We suspect
hat, in this strain, expression of the downstream genes
fgKJ is being driven by the same promoter that con-
rols kan expression.
Recall that both the polar and nonpolar yfgL alleles
except for yfgL::kan, see below) confer resistance to
ile salts and CBPV in the imp4213 background. In-
eed, the drug sensitivity profiles of both types of mu-
ations are identical. Therefore, it is the lack of func-
ional YfgL that is responsible for antibiotic resistance
n this strain. The different growth rates observed with
arious yfgL alleles do not alter these phenotypes.
enetic Interactions between imp and yfgL
s noted above, our data show that the lack of YfgL
ecreases the OM permeability of imp4213 cells, caus-
ng increased resistance to bile salts, CBPV, and moe-
omycin. Paradoxically, in an imp+ background, cells
arrying any of the yfgL mutant alleles exhibit increased
M permeability; they are more sensitive to antibiotics
uch as bacitracin, CBPV, novobiocin, and erythromy-
in than their wild-type parents (Table 1). Yet, in combi-
ation, imp4213 and yfgL confer resistance to bile
alts, CBPV, and moenomycin (Table 1). Thus, we have
situation in which, individually, yfgL and imp4213 both
onfer sensitivity to a variety of antibiotics, but the
Small Molecules Probes of Outer Membrane Assembly
313double mutants are resistant. Since the double mutants
exhibit phenotypes different from either singly mutant
parent, it is a synthetic phenotype.
We have found a second synthetic phenotype with
Imp and YfgL. Although neither imp4213 nor any of the
yfgL null mutations are lethal by themselves, both the
yfgL::kan and yfgL8 alleles are lethal in combination
with imp4213 (Table 2). We first noticed this synthetic
lethality when attempting to construct the yfgL::kan
imp4213 double mutant. Using P1 transduction fol-
lowed by selection in rich media, we were unable to
introduce either allele into the corresponding single
mutant background. We know that imp4213 cells defi-
cient in YfgL are viable; that is how the yfgL mutations
were identified. Moreover, we can overexpress YfgK
when we introduce pJT37 into imp4213 cells, since
overproduced YfgK can be simply detected by Coo-
massie blue staining after electrophoresis of cell ex-
tracts (data not shown). Therefore, the synthetic lethal-
ity that we find between the imp4213 and yfgL::kan
alleles cannot be explained by proposing either a toxic-
ity caused by upregulation of yfgK or the lack of func-
tional YfgL.
As noted above, yfgL::kan does not affect growth in
otherwise wild-type cells (Table 2). Because the various
yfgL alleles affect growth differently, we considered the
possibility that this might play a role in the synthetic
lethality observed with the imp4213 and yfgL::kan al-
leles. In other words, synthetic lethality is prevented in
yfgL::IS1E imp4213 strains because growth is compro-
mised by downregulation of the essential gene yfgK.
To address this possibility, we tested whether we
could introduce the yfgL::kan allele into imp4213 cells
if we slowed their growth. To this end, we performed
P1 transductions using imp4213 as recipient and se-
lecting for yfgL::kan on either rich (Luria-Bertani, LB) or
minimal medium conditions. Although we were unable
to obtain transductants when selecting on LB agar,
transductants did appear on minimal glycerol agar. Fur-
thermore, these transductants could only be propa-
gated in minimal medium. Similarly, if the imp4213 re-
cipient also carried a pstS null mutation, which is
known to slow growth (Ruiz and Silhavy, 2003), we
could then introduce the yfgL::kan allele by P1 trans-
duction even if selection was performed on LB medium.Table 2. Phenotypes of the Various yfgL Alleles in the imp+ and imp4213 Backgrounds
yfgL Alleles
Relevant genotype Relevant phenotypes yfgL::IS1E yfgL8 yfgL::kan
imp+ yfgK expression Reduced Wild-type Wild-typee
Growth defecta Severe None None
CBPV sensitivityb S S S
imp4213 Conditional synthetic lethality No Yesd Yes
CBPV sensitivityc R Rd N/Af
a Determined in LB medium.
b A sensitive (S) strain is one that, in a disk diffusion assay for CBPV, shows a zone of inhibition of growth larger than its yfgL+ parent.
c A resistant (R) strain is one able to grow on the LB agar containing 4 g/ml CBPV.
d The original imp4213 yfgL8 isolate carries an uncharacterized mutation that suppresses the synthetic lethal phenotype. This isolate was
used to determine sensitivity to CBPV.
e The expression of yfgK is probably under the control of the promoter of the kan cassette.
f N/A, not applicable.We conclude that the synthetic lethality of yfgL null mu-
tations and imp4213 is conditional; it is only evidenced
in rapidly growing cells.
As stated above, the imp4213 and yfgL8 alleles also
exhibit this conditionally synthetic lethal phenotype.
The original imp4213 yfgL8 double mutant was ob-
tained in a selection for mutants resistant to bile salts.
This original isolate contains an uncharacterized sup-
pressor mutation that allows the double mutant to sur-
vive. We know this because this isolate can be used as
an yfgL8 donor in a transduction cross if the recipient
strain is imp+ but not if the recipient carries imp4213.
We suggest that this uncharacterized suppressor slows
growth sufficiently to allow the double mutant to sur-
vive. Indeed, this uncharacterized mutation can also
suppress the synthetic lethality between the imp4213
and yfgL::kan alleles, since we can introduce the yfgL::
kan allele into the original imp4213 yfgL8 double mu-
tant even if the selection was performed on LB media.
Moreover, we can introduce the yfgL8 allele into an
imp4213 strain if selection is done on minimal glycerol
agar. Therefore, the only yfgL mutations that can be
moved by transduction into the imp4213 strain if the
selection is performed on rich media are the polar yf-
gL::IS1E insertions. This likely explains why these mu-
tations appeared so frequently in our selections for re-
sistance to CBPV or moenomycin, which were done on
LB agar. In hindsight, we inadvertently demanded them
because they simultaneously remove YfgL to confer an-
tibiotic resistance and suppress synthetic lethality by
reducing YfgK levels to slow cell growth.
The results presented above indicate that yfgL null
mutations and imp4213 cannot exist in the same strain
unless growth is slowed by either downregulating yfgK
expression or using minimal glycerol medium, or if
some additional unidentified suppressor is present (Ta-
ble 2). We conclude that a yfgL null allele and imp4213
are a conditionally lethal synthetic pair.
Taken together, the synthetic phenotypes docu-
mented in this section argue strongly for an interaction
(direct or indirect) between Imp and YfgL.
The yfgL Mutations Decrease the Levels
of OM Proteins
imp+ yfgL mutants have decreased levels of OM β bar-
rel proteins such as LamB and OmpA (Figure 5A). Since
Cell
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2(A) Logarithmically growing cells were subjected to Western blot
tanalysis for Imp, LamB, and OmpA. A strain carrying the yfgL::kan
allele had decreased levels of LamB and OmpA when compared to c
wild-type (wt) but had a similar amount of Imp. On the contrary, a s
dsbA mutant contains wild-type levels of LamB and OmpA but re- n
duced levels of Imp, since DsbA participates in Imp assembly f(Braun and Silhavy, 2002; Kadokura et al., 2004).
s(B) Overnight cultures were subjected to Western blot analysis for
LLamB. Cells lacking either SurA or YfgL contain reduced levels of
othe outer membrane protein LamB. The levels of LamB are reduced
even further in the double mutant. O
c
a
LamB and OmpA are not coregulated, we suspect d
these decreased levels in the yfgL mutants reflect an s
assembly defect. This defect, however, is not as severe c
as those found in cells lacking SurA, a periplasmic i
chaperone with peptidyl-proline isomerase activity (La- (
zar and Kolter, 1996; Rouviere and Gross, 1996). Be- l
cause the assembly defects caused by surA and yfgL w
are additive (Figure 5B), i.e., they are worse in the o
double mutant than in either of the singly mutant par- i
ents, we believe that SurA and YfgL affect different
steps of OM biogenesis. c
Together, these data argue a role for YfgL in OM bio- t
genesis. a
r
Discussion t
t
Small molecules that interfere with cellular processes l
ahave been invaluable tools in biology. For decades,actors involved in essential cellular functions that are
argets for such small molecules have been identified
sing genetic screens and selections. For example, se-
ection for rifampicin resistance was used to identify
he gene for a subunit of RNA polymerase in E. coli
Tocchini-Valentini et al., 1968; Ezekiel and Hutchins,
968). We set out to identify the direct target of a glyco-
ipid derivative of vancomycin and discovered that
hallenging E. coli imp4213 with this molecule elicited
remarkably specific response. After repeated selec-
ions, only one solution to the challenge, other than in-
ragenic imp suppressors, emerged: loss-of-function
utations in a gene called yfgL. Because the lack of
fgL also confers resistance to another transglycosyla-
ion inhibitor (moenomycin) but not to any other antibi-
tic examined, we thought initially that YfgL might
omehow sense the status of the peptidoglycan (Eg-
ert et al., 2001). However, results presented here sug-
est another role for YfgL. First, removing YfgL in a
ild-type background confers sensitivity to CPBV and
oenomycin, as well as other unrelated antibiotics with
ifferent structures and mechanisms, suggesting a
eneral defect in OM permeability. Second, the ab-
ence of YfgL in the imp4213 strain confers resistance
ot only to CPBV and moenomycin but also to bile
alts. Thus, rather than identifying the direct target of
BPV, we have discovered a gene, yfgL, that appears
o be involved in maintaining OM integrity in E. coli.
It is not known how the OM is assembled and main-
ained, although a few genes essential for the process,
ncluding imp, have been identified recently (Braun and
ilhavy, 2002; Voulhoux et al., 2003; Narita et al., 2004).
ells depleted of Imp appear to mislocalize newly syn-
hesized OM proteins and lipids (Braun and Silhavy,
002). However, in depletion experiments, it is some-
imes difficult to distinguish the primary defect from se-
ondary consequences that occur as cells die. In Neis-
eria, where LPS is not an essential component, imp is
ot an essential gene, and cells lacking Imp have de-
ects in LPS assembly in the OM (Bos et al., 2004). They
uggest that E. coli imp4213 cells likely have defects in
PS assembly, and we agree. Indeed, neither we nor
thers (Sampson et al., 1989) can detect changes in
M protein levels in E. coli imp4213 cells, and this is
onsistent with the proposal that this allele more likely
ffects the lipid composition of the OM. However, we
o not agree with their suggestion that imp4213 cells
imply have less LPS in their OM. Their simple model
annot explain why some of the phenotypes of
mp4213 cells are recessive, while others are dominant
Sampson et al., 1989). The recessive phenotypes are
ikely the consequence of a loss of function and may
ell be due to less LPS, but dominance requires gain
f function and implies that the mutant Imp4213 protein
s actively causing some additional OM alterations.
Nevertheless, the partial loss of Imp function in cells
arrying imp4213 and their wild-type levels of OM pro-
eins support the idea that the OM of imp4213 cells
re defective in LPS, and the permeability defects likely
esult from phospholipids that have been translocated
o the outer leaflet to fill the void (Nikaido, 2003). On
he other hand, YfgL is needed to maintain wild-type
evels of OM β barrel proteins. YfgL may act directly
s a nonessential component of the protein assembly
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315machinery and/or indirectly by regulating the various
machineries that function to assemble the OM. Given
our findings, we propose the different activities of Imp
and YfgL must be coordinated in order to maintain the
proper balance between LPS, phospholipids, and pro-
teins. Shifting this balance, by compromising either Imp
or YfgL, therefore results in increased OM permeability.
If the LPS component is altered in imp4213 cells, the
lack of YfgL might then restore the balance sufficiently
to correct some (bile salt and CBPV sensitivity) but not
all permeability defects. Thus, both mutations deleteri-
ously alter the OM composition, but they do so by dif-
ferent mechanisms.
This proposal offers a satisfying explanation for the
conditional synthetic lethality of the imp4213 and yfgL
null alleles; cells cannot tolerate both defects in OM
biogenesis unless growth is compromised. Such strict
conditions for cell viability and suppression might also
explain why only loss of function of YfgL and, in partic-
ular, why only specific types of yfgL mutations an-
swered our selection. Further evidence for a role for
YfgL in OM biogenesis is presented in the accompany-
ing paper (Wu et al., 2005). The function of nonessential
genes is often difficult to ascertain without the ability
to measure obvious phenotypes. Given the subtle de-
fects of a yfgL mutant, it would have been difficult to
identify YfgL as a player in OM biogenesis without the
use of CBPV and the bile salts, i.e., chemical condition-
ality.
Our results demonstrate a continuum of suppressor
quality and quantity (Figure 2B). All of the compounds
we employ in our selections must cross the OM perme-
ability barrier to act. The imp4213 mutation disrupts the
barrier and allows this to occur. All of the suppressors
confer resistance by restoring, to varying extents, bar-
rier quality. The inverse relationship between quality
and quantity reflects the number of genes that can be
mutated to confer a suppressor phenotype. Restoring
sensitivity to bile salts is relatively easy, and there are
multiple genetic targets. Restoring resistance to vanco-
mycin or erythromycin is difficult, and only specific in-
tragenic mutations in imp answer these selections.
Since resistance reflects changes in permeability, the
molecules we employ must be specific probes of bar-
rier quality, and the specificity of these probes must
reflect the different physical properties of these mole-
cules. We do not yet understand the physical basis of
the specificity. However, CBPV and moenomycin have
amphipathic physical characteristics, a property they
share with the bile salts but not with vancomycin. The
chlorobiphenyl modification of vancomycin allowed us
to discover the continuum. In a similar vein, we think it
should be possible to expand the continuum further by
chemically altering the physical properties of these
molecules.
The use of chemical probes in biology is most often
conceived in terms of a one molecule-one protein
match (Schreiber, 2003). Phenotypic alterations of a
cellular response to a particular small molecule are typ-
ically thought to result from mutations in the gene en-
coding the target of the molecule or a closely related
protein (Shah et al., 1997). Here we have shown that
antibiotics can elicit highly specific genetic phenotypes
that do not involve mutations in the genes for their di-rect targets but rather in genes that affect their ability
to reach their targets. Antibiotic action is a multistep
process: (1) passage of the antibiotic across the mem-
brane(s) to reach the cellular compartment where its
target resides, (2) interaction of the antibiotic with its
target, and (3) downstream events that lead to cell
death or growth inhibition. Since membranes surround
cellular compartments and since resistance to an anti-
biotic can be accomplished by preventing its entry into
the cellular compartment where its target is located,
antibiotics can function as probes of membrane integ-
rity. In E. coli, the machinery involved in peptidoglycan
biosynthesis is protected by an OM permeability bar-
rier. We used a series of compounds with targets inside
the cell to identify genes required to assemble the OM.
We have shown that this membrane can be rendered
generally permeable to a range of small molecules by
individual mutations in several genes, including imp
and yfgL, or it can be rendered selectively permeable
through combinations of mutations. Selective perme-
ability can only be revealed through the use of an ap-
propriate set of small molecule probes that create
chemically conditional phenotypes. The mutations that
confer both general and selective permeability provide
insight into the machinery involved in assembling
the OM.
It is possible to chemically modify many bioactive
small molecules to produce derivatives having varying
physical properties. Assuming that the composition of
other biological membranes (or organelles) is also
tightly controlled by the action of some molecular ma-
chine, it should be possible to shed light on the compo-
nents of the machine through the deliberate use of sets
of small molecules having targets inside the membrane
(or organelle) of interest.
Experimental Procedures
Growth Conditions
Luria-Bertani (LB), lactose MacConkey agar, and M63 glycerol or
glucose minimal agar media were prepared as described previously
(Silhavy et al., 1984). All liquid cultures were grown under aeration
at 37°C, and their growth was monitored by measuring the optical
density at 600 nm (OD600). Tetracycline and kanamycin were used
at a concentration of 25 g/ml. Chloramphenicol was used at a
concentration of 15 g/ml for strains carrying the imp4213 allele
and of 20 g/ml for those carrying the imp wild-type allele.
Bacterial Strains
For strain construction and genetic mapping, P1 transduction was
used to introduce alleles into the appropriate strains as described
previously (Silhavy et al., 1984). All strains carrying the imp4213
allele were derived from NR698. NR698 was constructed by intro-
ducing the imp4213 allele of BE100 (Eggert et al., 2001) into
MC4100 (Casadaban, 1976) as follows. A carB::Tn10 allele, which
is ca. 20%–25% linked to the imp locus, was introduced into BE100
by P1 transduction. Tetracycline-resistant transductants were
screened for the presence of the imp4213 allele by their inability to
grow on MacConkey agar. One such transductant (NR685) was
used as a donor in a transduction cross with MC4100, where we
selected for tetracycline-resistant transductants. By screening for
their inability to grow on MacConkey agar, we determined that ca.
22% of transductants carried the imp4213 allele. One such trans-
ductant (NR693) was then used as the recipient in the following
transduction. Because carB null mutants cannot grow on minimal
media (Gigot et al., 1980), we selected for the replacement of the
carB::Tn10 allele with the wild-type carB allele from MC4100 by
Cell
316selecting for growth on M63 minimal glucose media. A carB+ trans- c
pductant that retained the imp4213 allele (i.e., cannot grow on Mac-
Conkey agar) was named NR698. b
eNR698 was used as the starting strain in the selections for CBPV
and moenomycin-resistant mutants. In the selection for spontane- a
tous bile salt-resistant mutants, we used either NR698 or NR701,
which is a derivative of NR698 that carries the yfhS::Tn10 allele. S
dThe yfhS::Tn10 allele allows us to easily identify mutations linked
to the yfgL locus. The imp61 and yfgL8 alleles were isolated as c
tsuppressors of bile salt sensitivity of NR698 and NR701, respec-
tively. 1
rThe yfgL::IS1E allele from an isolate of BE103 carrying the
yfhS::Tn10 allele (Eggert et al., 2001) was introduced into MC4100 u
pby cotransduction with the yfhS::Tn10 allele, and the new strain
was named NR452-2. One transductant that was yfhS::Tn10 and s
tyfgL+ was named NR453-2. The yfgL::Tn5KAN-I-SceI (referred to
as yfgL::kan) allele was derived from strain FB22443, which we ob- B
tained from the E. coli Genome Project at the University of Wiscon-
sin-Madison (http://www.genome.wisc.edu/functional/tnmutagenesis. Y
htm). We constructed strain NR721 by introducing the yfgL::kan A
allele into MC4100 by P1 transduction. The yfgL::kan allele of Q
NR721 was replaced with the yfgL8 allele by cotransduction with a
the yfhS::Tn10 of the original NR701 bile salt resistant isolate. The c
resulting strain was named NR722. A surA::cam allele (from our
laboratory collection) was introduced into MC4100 and NR721 to
create NR740 and NR742, respectively. A dsbA::kan allele (from our A
laboratory collection) was introduced into MC4100 to create
NR713. W
To map mutations in the yfgL locus, we used the linked a
yfhS::Tn10 and guaA::cam alleles. To map mutations in the imp a
locus, we used the linked carB::Tn10, leuO::Tn10, and apaG::cam T
alleles. (
Selections R
Spontaneous CBPV-resistant mutants were selected as previously R
described (Eggert et al., 2001). To select for bile salt-resistant mu- A
tants, we plated 0.1 ml of overnight LB broth cultures of NR701 P
onto lactose MacConkey agar. Spontaneous bile salt-resistant mu-
tants appeared after overnight incubation at 37°C. Moenomycin re- R
sistant mutants were obtained by plating onto LB agar containing
0.1 g/ml moenomycin. Strain NR698 was mutagenized with NTG A
as previously described (Silhavy et al., 1984). Mutations were iden- R
tified by DNA sequencing after genetic mapping. For DNA se- p
quencing, the allele of interest was amplified by PCR directly from w
chromosomal DNA, and products were purified using the QIAquick
BPCR purification kit (Qiagen). DNA sequencing was done by the
MPrinceton University Department of Molecular Biology Synthesis
aand Sequencing Facility using primers specific to the gene of in-
Bterest.
t
oCompound Sensitivity
SBile salt sensitivity was assessed by the ability of the strain to grow
Bor not on lactose MacConkey agar. The sensitivity to CBPV and
evancomycin of strains carrying the imp4213 allele was determined
1by assessing growth on LB agar containing either compound at a
final concentration of 4 g/ml CBPV or 2 g/ml vancomycin. The C
sensitivity to CBPV of strains carrying the imp+ allele was deter- t
mined by disk diffusion assay as described below using 6 mm filter l
paper disks (Schleicher & Schuell) impregnated with 150 g of E
CBPV. BBL Sensi-Discs Antimicrobial Susceptibility Test Discs R
(BBL) were used to test strain sensitivity to bacitracin, novobiocin, d
erythromycin, and rifampin. Disks containing the aforementioned c
compounds were used in disks diffusion assays as follows. A 0.1
E
ml inoculum taken from overnight LB broth cultures was mixed with
p
3 ml of molten LB top agar and poured over an LB agar plate. The
c
disks containing antibiotics were placed on top of the LB top agar,
Gand the plates were incubated overnight at 37°C. The diameter of
mthe zone of inhibition of growth around each disk was recorded
rin millimeters.
G
dProtein Analysis
rFor protein analysis, 1 ml samples were taken either from logarith-
mic (OD of 0.5–0.6) or overnight LB broth cultures. Samples were H600entrifuged (16,000 × g for 5 min), and to standardize samples,
ellets were resuspended in a volume (in milliliters) of SDS sample
uffer equal to OD600/6. Samples were boiled for 10 min, and
qual volumes were subjected to electrophoresis in 10% polyacryl-
mide gels containing SDS as described by Laemmli (1970). Pro-
eins were transferred to nitrocellulose membranes (Schleicher &
chuell), and Western blot analysis was performed as previously
escribed (Gibson and Silhavy, 1999). When appropriate, poly-
lonal sera raised against Imp and YfgL (from our laboratory collec-
ion, see below) were used as primary antibodies at a dilution of
:7000. These antisera also recognize OmpA. Polyclonal antiserum
aised against denatured LamB (from our laboratory collection) was
sed at a dilution of 1:10,000. Donkey anti-rabbit IgG horseradish
eroxidase conjugate (Amersham Pharmacia Biotech) was used as
econdary antibody at a 1:6000 dilution. For visualization of bands,
he ECL antibody detection kit (Amersham Pharmacia Biotech) and
iomax film (Kodak) were used.
fgL Antiserum
n antibody raised in a rabbit against a peptide (NAc-CDSSGF
TEPVAADGKLLIQAKDGTVYSITR-COOH) containing the last 30
mino acids of YfgL was obtained from Rockland Immunochemi-
als, Inc. (Gilbertsville, PA).
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